Advertisement

Heart and Lung Retransplantation

  • M. R. Mill
  • E. B. Stinson

Abstract

Cardiac transplantation has become an accepted and well-established treatment for end-stage cardiac disease (Baumgartner et al. 1979). Severe myocardial dysfunction which is not treatable by standard medical therapy or conventional surgical intervention can result from end-stage coronary artery disease, valvar heart disease or cardiomyopathies including idiopathic dilated cardiomyopathy, viral cardiomyopathy and postpartum cardiomyopathy. The recent interest in paediatric cardiac transplantation has extended the indications for cardiac transplantation to include complex congenital cardiac anomalies for which conventional procedures are either not possible or have previously provided insufficient palliation. At Stanford University Medical Center an active clinical cardiac transplantation programme has existed since 1968. Over the past 19 years 474 transplants in 432 recipients have been performed. The survival rates in the era of immunosuppression with cyclosporine are 83% at 1 year and 65% at 5 years. As the experience has grown, the need for retransplantation has developed (Copeland et al. 1977), and to date 40 retransplants have been performed in 38 recipients.

Keywords

Graft Rejection Cardiac Transplantation Constrictive Pericarditis Donor Heart Polypropylene Suture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baumgartner WA, Reitz BA, Oyer PE, Stinson EB, Shumway NE (1979) Cardiac transplantation. Curr Probl Surg 16: 1–6PubMedCrossRefGoogle Scholar
  2. Billingham ME, Baumgartner WA, Watson DC et al. (1980) Distant heart procurement for human transplantation. Circulation 62 (suppl I): 1–11–19Google Scholar
  3. Burke CM, Theodore J, Dawkins KD et al. (1984) Post-transplant obliterative bronchiolitis and other late sequelae in human heart-lung transplantation. Chest 86: 824–9PubMedCrossRefGoogle Scholar
  4. Copeland JG, Griepp RB, Bieber CP et al. (1977) Successful retransplantation of the human heart. J Thorac Cardiovasc Surg 73: 242–247PubMedGoogle Scholar
  5. Dawkins KD, Jamieson SW, Hunt SA et al. (1985) Longterm results, haemodynamics, and complications after combined heart and lung transplantation. Circulation 71: 919–926PubMedCrossRefGoogle Scholar
  6. Jamieson SW (1986) Transplantation. In: Jamieson SW, Shumway NE (eds) Rob and Smith’s operative surgery: cardiac surgery. Butterworths, London, pp. 584–605Google Scholar
  7. Jamieson SW, Stinson EB, Oyer PE, Baldwin JC, Shumway NE (1984a) Operative technique for heart-lung transplantation. J Thorac Cardiovasc Surg 87: 930–935PubMedGoogle Scholar
  8. Jamieson SW, Stinson EB, Oyer PE et al. (1984b) Heart-lung transplantation for irreversible pulmonary hypertension. Ann Thorac Surg 38: 554–562PubMedCrossRefGoogle Scholar
  9. Oyer PE, Shumway NE (1974) Again, via the median sternotomy. Arch Surg 109: 604PubMedGoogle Scholar
  10. Watson DC, Reitz BA, Baumgartner WA et al. (1979) Distant heart procurement for transplantation. Surgery 86: 56–59PubMedGoogle Scholar
  11. Zusman DR, Stinson EB, Oyer PE et al. (1985) Determinants of accelerated graft atherosclerosis in conventional and cyclosporine treated heart transplant recipients. Heart Trans 4: 587–591Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • M. R. Mill
  • E. B. Stinson

There are no affiliations available

Personalised recommendations